โจทย์ ปรนัย
What is the primary goal of the article according to its introduction?

The introduction explains that generative AI has become an important tool for creating synthetic medical imaging data that closely resemble real patient data. The article aims to explore the advantages of these datasets like improving data diversity and protecting patient privacy. It also discusses practical applications in areas like medical education, rare disease research, and radiology. In addition, the writer address ethical concerns and limitations that may affect clinical implementation. Overall, the paper provides an overview of both the opportunities and challenges of synthetic data in medical imaging.

There are 4 main theories that are used in consideration in this question. Generative AI which refers to the AI model that can create new data that resemble real medical images. Synthetic Data which refers to Artificially generated data can supplement or replace limited real-world datasets. Data Privacy which refers to Synthetic data may help protect patient confidentiality while supporting research. Medical Imaging which refers to AI-generated images can improve research, education, and clinical workflows.

โจทย์ ปรนัย
How do generative AI models differ from traditional discriminative models in healthcare applications?

The paper explains that generative AI models can create synthetic datasets that closely resemble real medical data. Unlike traditional discriminative models , which analyse, classify, or interpret existing data, generative models learn the underlying patterns in the data and generate entirely new examples. This ability makes them useful for data augmentation, medical education, and research.

Generative AI refers to AI models that create new data by learning patterns from existing datasets, while discriminative AI focuses on analysing existing data to classify, predict, or identify patterns. Both are applications of machine learning, where algorithms learn from data to perform specific tasks. In healthcare, generative AI can be used for synthetic data generation, producing realistic medical images that supplement real datasets and support research, education, and clinical development.

โจทย์ ปรนัย
What is meant by the term “model as a dataset”?

The paper explains the idea of a “model as a dataset,” where a trained generative AI model captures the patterns of the original dataset and generate new synthetic data when needed. Instead of sharing sensitive patient data directly, researchers may share the model weights, allowing others to create realistic synthetic datasets while reducing privacy concerns.

This concept combines generative AI, which learns patterns from real data to create new examples, synthetic data generation, where artificial datasets are produced from a trained model, machine learning, where knowledge is stored within model parameters , and data privacy, which aims to protect patient information by avoiding the direct sharing of raw medical data.

โจทย์ ปรนัย
Which statement correctly distinguishes physics-informed and statistical models?

The paper explains that physics-informed models integrate known physical, biological, or physiological principles into the data generation process. This helps ensure that the synthetic images produced are consistent with real-world medical and physical constraints. The other options are incorrect because statistical models are not simply rule-based, are not limited to MRI reconstruction, and both approaches still require domain expertise for development and validation.

This question involves physics-informed modelling, which incorporates established physical or biological knowledge into AI models, and statistical modelling, which learns patterns from data without explicitly relying on physical laws. Both approaches are used in generative AI to create realistic synthetic medical data, while machine learning provides the framework that allows models to learn and generate data.

โจทย์ ปรนัย
According to the article, what does the “image generation trilemma” describe?

The paper refers to the "image generation trilemma" as the challenge of producing images that are realistic, varied, and generated efficiently at the same time. Improving one aspect often comes at the expense of another, meaning it is difficult for a model to optimize and maximize all three at the same time. This trade-off is an important consideration when developing generative AI systems for medical imaging.

This concept relates to generative AI, where models create new synthetic images by learning patterns from existing data. It also involves image synthesis, which aims to generate realistic and diverse images, and machine learning optimization, where trade-offs often occur between competing objectives such as quality, diversity, and computational efficiency. Understanding these trade-offs helps researchers choose the most suitable model for a specific medical imaging application.

โจทย์ ปรนัย
What is the Human Turing Test used for in medical image synthesis?

The Human Turing Test is used to determine whether experts, such as radiologists, can tell the difference between real and AI-generated medical images. If experts cannot reliably distinguish between the two, it suggests that the synthetic images are highly realistic. This helps researchers evaluate the quality and usefulness of generated images before they are applied in medical research or clinical settings.

This question involves generative AI, which creates synthetic medical images that resemble real ones, and image synthesis, where AI generates new images from learned patterns in existing data. The Human Turing Test is a method of human evaluation that measures how realistic these images appear to experts, while medical image validation ensures that generated images are accurate and suitable for healthcare applications.

โจทย์ ปรนัย
Which of the following is NOT mentioned as a potential benefit of synthetic data in healthcare?

The paper highlights several benefits of synthetic data, including increasing data diversity, protecting patient privacy, supporting medical education, and enabling collaboration between multiple healthcare centers. However, it does not claim that synthetic data can completely remove all medical biases. In fact, the article discusses bias as an ongoing challenge, since AI models can sometimes learn and reproduce biases that already exist in the original data.

This question relates to synthetic data generation, where AI creates realistic medical data for research and training, and data privacy, which helps protect patient information. It also involves bias in AI, where models may inherit patterns and limitations from their training data, meaning biases cannot be completely eliminated. These concepts are important in healthcare AI, where fairness and reliability are essential for safe clinical use.

โจทย์ ปรนัย
What is one major ethical concern associated with generative AI in medical imaging?

The paper highlights patient privacy as a major ethical concern when using generative AI in medical imaging. Although synthetic data are designed to protect privacy, there are still risks that AI models may reproduce information from the original training data. In some cases, this could lead to patient reidentification, where sensitive information about individuals may be exposed. This is one of the main challenges that must be addressed before wider clinical use.

This question involves data privacy, which focuses on protecting sensitive patient information, and generative AI, which learns patterns from existing datasets to create new images. It also relates to synthetic data generation, where artificial data are used to reduce the need for sharing real patient records, and AI ethics, which ensures that these technologies are used safely and responsibly in healthcare.

โจทย์ ปรนัย
What regulatory precedent did the article cite for synthetic data technologies?

The article refers to the FDA clearance of synthetic MRI technology as an important regulatory precedent for synthetic data technologies in healthcare. This example shows that regulatory bodies are beginning to evaluate and approve AI-related imaging tools for clinical use. It demonstrates that synthetic imaging technologies can meet regulatory standards when they are shown to be safe, effective, and reliable.

This question involves medical imaging regulation, which ensures that new healthcare technologies are safe before being used in patients, and generative AI, which can create or enhance medical imaging data. It also relates to clinical validation, where technologies must be tested to prove their effectiveness, and healthcare innovation, where regulatory approval helps new tools move from research into real world clinical practice.

โจทย์ ปรนัย
What is the main purpose of the article?

The article reviews ASCVD risk prediction models used in China, Japan, and South Korea and compares how they perform in East Asian populations. It discusses why commonly used Western models, such as the Framingham Risk Score and PCE, often overestimate cardiovascular risk in East Asians and examines country-specific alternatives. The paper also highlights current challenges and future directions for improving risk prediction in this population.

This question involves cardiovascular risk prediction, which estimates a person's chance of developing ASCVD based on factors such as age, blood pressure, cholesterol, smoking, and diabetes. It also relates to epidemiology, which studies disease patterns in different populations, predictive modelling, where statistical tools are used to estimate future health outcomes, and population-specific medicine, which recognizes that risk calculators may need to be adapted for different ethnic and regional groups to improve accuracy.

โจทย์ ปรนัย
Which of the following models was originally developed for a Western population?

The Framingham Risk Score was developed from the Framingham Heart Study in the United States and is one of the major Western cardiovascular risk prediction models. The paper explains that when FRS was applied to Chinese and other East Asian populations, it often overestimated cardiovascular risk, which led researchers to develop country-specific models such as China-PAR, the Suita Score, and Korean risk prediction models.

This question involves cardiovascular risk prediction models, which estimate a person's future risk of ASCVD using risk factors such as age, blood pressure, cholesterol, smoking, and diabetes. It also relates to population-based epidemiology, where models developed in one population may not perform accurately in another, and risk calibration, which adjusts prediction tools so that estimated risks better match the actual disease rates of a specific population.

โจทย์ ปรนัย
Why might Western-based risk prediction models overestimate ASCVD risk in East Asian populations?

The paper explains that Western risk calculators, such as the Framingham Risk Score and PCE, were developed using populations with generally higher rates of cardiovascular disease. In East Asian countries, especially China, Japan, and South Korea, the incidence of coronary heart disease is often lower. As a result, when Western models are applied directly to East Asian populations, they tend to predict more ASCVD events than actually occur, leading to overestimation of risk.

This question involves cardiovascular risk prediction, where models estimate future disease risk using factors such as age, blood pressure, cholesterol, smoking, and diabetes. It also relates to epidemiology, which studies how disease rates differ between populations, and risk calibration, which ensures that a prediction model accurately reflects the disease patterns of the population in which it is used. If a model is applied to a population with different baseline disease rates, it may overestimate or underestimate risk.

โจทย์ ปรนัย
What is the key advantage of the China-PAR model compared to Western-based models?

The China-PAR model was developed using data from large Chinese cohort studies and includes participants from different geographic regions and backgrounds within China. The paper highlights that Western models such as the PCE performed poorly in Chinese populations, while China-PAR was specifically designed using Chinese population data. This makes it better suited to estimating ASCVD risk in Chinese individuals

This question involves population-specific risk prediction, where models are developed using data from the population they are intended to assess. It also relates to epidemiology, which studies disease patterns across different regions and groups, risk calibration, which improves the accuracy of predictions for a target population, and cardiovascular risk assessment, where factors such as blood pressure, cholesterol, smoking, diabetes, family history, and regional characteristics are used to estimate future ASCVD risk.

โจทย์ ปรนัย
Which of the following variables is not typically included in ASCVD risk prediction models discussed in the article?

The ASCVD risk prediction models discussed in the article commonly use traditional cardiovascular risk factors such as age, blood pressure, cholesterol levels, smoking status, and diabetes. Different models may include additional factors like family history, waist circumference, or geographic region, but genetic ancestry markers are not listed as standard variables in the major Chinese, Japanese, or Korean risk calculators reviewed in the paper

This question involves cardiovascular risk prediction, which estimates future ASCVD risk using established clinical risk factors that are easy to measure in routine healthcare settings. It also relates to epidemiology, where predictors are selected based on strong evidence linking them to disease outcomes, and risk modelling, which aims to balance accuracy with practical use in real-world clinical practice. Although genetic factors may influence cardiovascular risk, the models discussed in this article primarily rely on traditional clinical and lifestyle risk factors.

โจทย์ ปรนัย
What is a major difference between the Suita Score and the Framingham Risk Score?

The paper explains that the Suita Score was developed in Japan using data from Japanese populations to better estimate coronary heart disease risk in that specific population. In contrast, the Framingham Risk Score was developed from a U.S. population. Because disease patterns and risk factor distributions differ between Western and Japanese populations, the Suita Score is generally more suitable for risk assessment in Japan.

This question involves population-specific risk prediction, where risk calculators are developed using data from the population they are intended to serve. It also relates to epidemiology, which studies how disease rates vary across populations, risk calibration, which improves the accuracy of predictions for specific groups, and cardiovascular risk assessment, where factors such as age, blood pressure, cholesterol, smoking, and diabetes are used to estimate future disease risk. Models built from local data often perform better than imported models because they reflect the actual health patterns of that population.

โจทย์ ปรนัย
According to the article, what is a potential benefit of developing East Asia–specific risk models?

The article explains that Western risk calculators, such as the Framingham Risk Score and PCE, often overestimate ASCVD risk in East Asian populations because disease patterns differ from those in Western countries. East Asia–specific models are developed using local population data, making them better calibrated to the actual risk levels in China, Japan, and Korea. This can improve the accuracy of risk assessment and help guide more appropriate prevention and treatment decisions.

This question involves risk calibration, which ensures that a prediction model accurately reflects the disease rates of the population being studied. It also relates to cardiovascular risk prediction, where factors such as age, blood pressure, cholesterol, smoking, and diabetes are used to estimate future ASCVD risk, and population-specific medicine, which recognizes that models developed in one ethnic or regional group may not perform as well in another. Using local data helps produce more reliable risk estimates.

โจทย์ ปรนัย
Which factor was highlighted as influencing ASCVD risk differences among East Asian countries?

The article explains that ASCVD risk differs across East Asian countries because of variations in lifestyle, diet, and disease patterns. Factors such as dietary habits (including salt intake), smoking prevalence, and other cultural and environmental influences contribute to differences in cardiovascular disease risk between China, Japan, and South Korea. These differences are one reason why each country has developed its own risk prediction models rather than relying entirely on Western calculators.

This question involves epidemiology, which studies how disease patterns vary between populations, and cardiovascular risk factors, which include lifestyle and environmental influences such as diet, smoking, physical activity, and blood pressure. It also relates to population-specific medicine, which recognizes that health risks are shaped not only by biology but also by cultural and social factors. Because these factors differ between countries, ASCVD risk models need to be tailored to the populations they serve.

โจทย์ ปรนัย
What future direction does the article suggest for improving ASCVD risk prediction?

The article discusses future improvements in ASCVD risk prediction through the use of additional data sources, including imaging techniques, biomarkers, and newer prediction approaches. It also emphasizes the need for region-specific models and multinational collaboration to create more accurate risk calculators for East Asian populations. Combining advanced technologies with local population data could help improve risk assessment beyond traditional models.

This question involves predictive modelling, where different types of health information are combined to estimate disease risk. It also relates to artificial intelligence and machine learning, which can analyse large and complex datasets, multimodal prediction, where clinical data, imaging, and biomarkers are used together, and population-specific medicine, which aims to tailor risk assessment tools to the characteristics of specific populations. These approaches may improve the accuracy of ASCVD risk prediction in East Asians.

โจทย์ ปรนัย
Which statement best explains the key difference in how VAEs, GANs, and DDPMs generate medical images according to the figure?

The figure shows that the three generative AI models use different image-generation processes. VAEs generate images through an encoder–decoder architecture, while GANs generate images through competition between a generator and a discriminator. In contrast, DDPMs start with random noise and gradually remove that noise through a reverse diffusion process until a realistic image is formed. This reverse denoising approach is the key feature that distinguishes DDPMs from VAEs and GANs.

This question involves generative AI models, which create new data by learning patterns from existing datasets. VAEs (Variational Autoencoders) compress data into a latent representation and reconstruct it through a decoder. GANs (Generative Adversarial Networks) improve image realism using adversarial learning between a generator and a discriminator. DDPMs (Denoising Diffusion Probabilistic Models) generate images by repeatedly removing noise from an initially random image, gradually producing a realistic output. The figure highlights these different generation mechanisms and how they are applied to medical image synthesis.

โจทย์ ปรนัย
Which of the following best explains the trend shown in Figure comparing age-standardized and crude CVD mortality rates among East Asian countries?

The figure shows that Japan has consistently low cardiovascular disease (CVD) mortality in both crude and age-standardized rates. This means the low mortality is not only explained by population age structure, since both adjusted and unadjusted values remain low compared to other East Asian countries.

Crude mortality rate reflects total deaths in a population and is influenced by age distribution. Age-standardized mortality rate adjusts for differences in population age structure to allow fair comparison between countries. When both measures are low, it indicates a genuinely lower underlying CVD mortality risk that is not driven by demographic differences.